2013 Regular Session
|At the request of:|
|Bill Title:||Relating to biological products; and declaring an emergency.|
Restricts substitution of biosimilar product for prescribed biological product.
Becomes operative on January 1, 2014. Declares emergency, effective on passage.
|Chapter Number:||Chapter 342|
|Fiscal Impact:||Has Minimal Fiscal Impact|
|Revenue Impact:||No Revenue Impact|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||Chapter Number Assigned|
|Potential Conflicts of Interest/Vote Explanations:||Potential Conflicts of Interest/Vote Explanation Documents|